NCT02742883 2025-09-16
A Study of Atengenal and Astugenal in Diffuse, Intrinsic Pontine Glioma (DIPG)
Burzynski Research Institute
Phase 2 Suspended
Clinical Trials
14 trialsNCT00003458 2022-03-07
Antineoplaston Therapy in Treating Children With Brain Tumors
Burzynski Research Institute
Phase 2 Completed
NCT00003456 2018-03-22
Antineoplaston Therapy in Treating Patients With Newly-diagnosed Glioblastoma Multiforme
Burzynski Research Institute
Phase 2 Completed
NCT00003471 2018-03-22
Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003474 2018-03-22
Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme
Burzynski Research Institute
Phase 2 Completed
NCT00003535 2018-03-21
Antineoplaston Therapy in Treating Children With Recurrent or Refractory High-Grade Glioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003513 2017-09-28
Antineoplaston Therapy in Treating Patients With Metastatic, Recurrent, or Refractory Neuroblastoma
Burzynski Research Institute
Phase 2 Terminated
NCT00003470 2017-08-24
AA
Burzynski Research Institute
Phase 2 Completed
NCT00003475 2017-08-24
Antineoplaston Therapy in Treating Patients With Primary Malignant Brain Tumors
Burzynski Research Institute
Phase 2 Completed
NCT00003476 2017-08-24
Antineoplaston Therapy in Treating Children With Primary Malignant Brain Tumors
Burzynski Research Institute
Phase 2 Terminated
NCT00003483 2017-08-24
Antineoplaston Therapy in Treating Patients With Meningioma
Burzynski Research Institute
Phase 2 Terminated
NCT00003537 2017-08-24
AA
Burzynski Research Institute
Phase 2 Completed
NCT00003457 2017-08-22
Antineoplaston Therapy in Treating Patients With Brain Tumors
Burzynski Research Institute
Phase 2 Completed
NCT02988726 2017-07-26
Antineoplaston Therapy in Treating Patients With Neurofibroma and Schwannoma
Burzynski Research Institute
Phase 2 Terminated